InterventionsHuman trial

First-line pyrotinib plus apatinib in advanced non-small cell lung cancer harboring HER2 mutations or amplification: a phase II trial

Lung Cancer

The paper

Yaning Yang, Wenxin Jiang, Guangjian Yang,
Show 8 more authorsWeihua Li, Junling Li, Xuezhi Hao, Puyuan Xing, Siyu Lei, Fang Wei, Linyan Tian, Haiyan Xu,
Yan Wang

Inserm · Chinese Academy of Medical Sciences & Peking Union Medical College

Lung Cancer · 22 Aug 2026

doi.org/10.1016/j.lungcan.2026.109589PubMed 42691829

More in Interventions